ConductScience.org, home

Paper23945604

Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.

Jones H and 1 other. CPT Pharmacometrics Syst Pharmacol, 2013. Cited by 463 papers, by iCite.

Cite this record

ConductScience Library. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. Papers, record 23945604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23945604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.
PubMed
Journal
CPT Pharmacometrics Syst Pharmacol
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
463
iCite
Relative citation ratio, by iCite
18.2
iCite
Revised in PubMed
2023-01-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones HHm
2Rowland-Yeo KK

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117981004General approach for the calculation of tissue to plasma partition coefficients.Toxicol In Vitro2008https://conductscience.org/library/papers/17981004PubMed
210772639Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.Drug Metab Dispos2000https://conductscience.org/library/papers/10772639PubMed
39773391Lumping of whole-body physiologically based pharmacokinetic models.J Pharmacokinet Biopharm1998https://conductscience.org/library/papers/9773391PubMed
419199378The Simcyp population-based ADME simulator.Expert Opin Drug Metab Toxicol2009https://conductscience.org/library/papers/19199378PubMed
511576695Predicting the impact of physiological and biochemical processes on oral drug bioavailability.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11576695PubMed
619184451Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects.AAPS J2009https://conductscience.org/library/papers/19184451PubMed
715025742The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.Br J Clin Pharmacol2004https://conductscience.org/library/papers/15025742PubMed
816176562Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin.Basic Clin Pharmacol Toxicol2005https://conductscience.org/library/papers/16176562PubMed
920869379A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals.Toxicol Appl Pharmacol2010https://conductscience.org/library/papers/20869379PubMed
1022143261Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.J Pharmacokinet Pharmacodyn2012https://conductscience.org/library/papers/22143261PubMed
1117428153Whole-body physiologically based pharmacokinetic models.Expert Opin Drug Metab Toxicol2007https://conductscience.org/library/papers/17428153PubMed
1220170207A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.Clin Pharmacokinet2010https://conductscience.org/library/papers/20170207PubMed
1316928154Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.Clin Pharmacokinet2006https://conductscience.org/library/papers/16928154PubMed
1420368326Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.Drug Metab Dispos2010https://conductscience.org/library/papers/20368326PubMed
1519455625Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.J Pharm Sci2009https://conductscience.org/library/papers/19455625PubMed
1616520012Ionization, lipophilicity and solubility properties of repaglinide.J Pharm Biomed Anal2006https://conductscience.org/library/papers/16520012PubMed
1722644330Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22644330PubMed
1823598453Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?Clin Pharmacol Ther2013https://conductscience.org/library/papers/23598453PubMed
1922228214Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.Biopharm Drug Dispos2012https://conductscience.org/library/papers/22228214PubMed
2019479982Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.J Pharm Sci2010https://conductscience.org/library/papers/19479982PubMed

See all 70 referencesDownload CSV of references

Cited by287

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 463 citations.

PMIDTitleJournalYearIn PapersSource
42974179
A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation.
Int J Nanomedicine2026https://conductscience.org/library/papers/42974179PubMed
42953428Advanced drug delivery and PBPK modelling as translational tools for precision therapies in juvenile idiopathic arthritis.Front Pharmacol2026https://conductscience.org/library/papers/42953428PubMed
42942786PBPK Modeling Investigation of IVIVE-Observed Pharmacokinetic Divergence for VU0467319: A Mechanistic Refinement Workflow for Low-Solubility Compounds.Pharmaceutics2026https://conductscience.org/library/papers/42942786PubMed
42927046Hybrid Mechanistic-Neural Modeling of Concentration-Time Dynamics Generalizes Human Pharmacokinetics Prediction Across Unseen Chemical Space.bioRxiv2026https://conductscience.org/library/papers/42927046PubMed
42867201Overview of Regulatory Guidelines Related to Methods and Models for Small Populations.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42867201PubMed
42761162Integration of microphysiological systems with computational and digital twin modeling for pharmaceutical development: a systematic review.J Pharm Pharm Sci2026https://conductscience.org/library/papers/42761162PubMed
42745804Physiologically-based pharmacokinetic model to predict loading dose polymyxin B exposure in critically ill patients with sepsis.Front Pharmacol2026https://conductscience.org/library/papers/42745804PubMed
42682178Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib.Clin Transl Sci2026https://conductscience.org/library/papers/42682178PubMed
42670843Gaps in AI-Driven Pharmacokinetic Property Prediction for Early Drug Development: A Scoping Review.J Chem Inf Model2026https://conductscience.org/library/papers/42670843PubMed
42654079Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling.Pharmaceutics2026https://conductscience.org/library/papers/42654079PubMed
42622756Microplastics as carriers of environmental contaminants: Implications for human exposure, toxicokinetics, and health risk.Environ Geochem Health2026https://conductscience.org/library/papers/42622756PubMed
42618963Transitioning from Transcriptomics to Proteomics: Enhancing Mechanistic Accuracy in PBPK Modeling via Absolute Protein Abundances.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42618963PubMed
42539599Physiologically based pharmacokinetic modeling of tafenoquine and evaluation of transporter-mediated drug-drug interactions.Front Pharmacol2026https://conductscience.org/library/papers/42539599PubMed
42535720From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development.J Clin Pharmacol2026https://conductscience.org/library/papers/42535720PubMed
42529478Scientific Opinion on waiving of the dog studies in the regulatory process of agrochemicals approval.EFSA J2026https://conductscience.org/library/papers/42529478PubMed
42514902Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions.Pharmaceutics2026https://conductscience.org/library/papers/42514902PubMed
42495293Integrating Experimental Physicochemical Data with PBPK Modeling to Guide the Translational Development of the Antifungal 1,3,4-Oxadiazole Derivative LMM6.ACS Omega2026https://conductscience.org/library/papers/42495293PubMed
42435187Mathematical Modeling in Cancer Metabolism: Tools for Translational Applications in Metabolism-Based Therapy.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435187PubMed
42400597Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42400597PubMed
42398834New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.J Control Release2026https://conductscience.org/library/papers/42398834PubMed

See all 287 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CYP2C81558PubTator's text mininghttps://conductscience.org/library/genes/1558NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
SLCO1A26579PubTator's text mininghttps://conductscience.org/library/genes/6579NCBI Gene
SLCO1B110599PubTator's text mininghttps://conductscience.org/library/genes/10599NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23945604

GET https://conductscience.org/api/papers/v1/23945604/references?page=2